SCHEMBL6448985

SCHEMBL6448985

CC(C)[C@H](NC(=O)OCc1ccncc1)C(=O)N[C@@H](Cc1ccccc1)[C@H](O)[C@@H](O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)OCc1ccncc1)C(C)C

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CTSD P07339 4/20 0.68
CA2 P00918 2/20 0.55
BACE1 P56817 5/20 0.53
TRPM8 Q7Z2W7 1/20 0.50
CTSL P07711 1/20 0.50
CTSS P25774 1/20 0.50
CASP3 P42574 1/20 0.50
REN P00797 1/20 0.50
PSMB11 A5LHX3 1/20 0.48
PSMA7 O14818 1/20 0.48
PSMB1 P20618 1/20 0.48
PSMA1 P25786 1/20 0.48
PSMA2 P25787 1/20 0.48
PSMA3 P25788 1/20 0.48
PSMA4 P25789 1/20 0.48
PSMB8 P28062 1/20 0.48
PSMB9 P28065 1/20 0.48
PSMA5 P28066 1/20 0.48
PSMB4 P28070 1/20 0.48
PSMB6 P28072 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6454320 1.00 CTSD (0.68) CTSDCA2BACE1TRPM8CTSL
SCHEMBL6449617 0.98 CTSD (0.68) CTSDCA2BACE1TRPM8CTSL
SCHEMBL7268574 0.98 CTSD (0.68) CTSDCA2BACE1TRPM8CTSL
SCHEMBL9740721 0.93 CTSD (0.76) CTSDCA2TRPM8CTSLCTSS
SCHEMBL6446780 0.93 CTSD (0.76) CTSDCA2TRPM8CTSLCTSS
SCHEMBL6446151 0.93 CTSD (0.76) CTSDCA2TRPM8CTSLCTSS
SCHEMBL6445103 0.93 CTSD (0.76) CTSDCA2TRPM8CTSLCTSS
SCHEMBL9232828 0.93 CTSD (0.76) CTSDCA2TRPM8CTSLCTSS
SCHEMBL7430958 0.92 BACE1 (0.61) CTSDBACE1
SCHEMBL6449641 0.91 CTSD (0.76) CTSDCA2TRPM8CTSLCTSS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0839798-B1 Intermediates for preparating non-peptide retroviral protease inhibitors ABBOTT LAB (US) 2005-08-17 EP disclosed
EP-0402646-B1 Retroviral protease inhibiting compounds ABBOTT LAB (US) 1998-07-22 EP disclosed
EP-0839798-A2 Intermediates for preparating non-peptide retroviral protease inhibitors ABBOTT LABORATORIES (US) 1998-05-06 EP disclosed
US-5545750-A TREATING HUMAN IMMUNODEFICIENCY VIRUS ABBOTT LABORATORIES (US) 1996-08-13 US disclosed
US-5142056-A Human immunodeficiency virus protease inhibitor ABBOTT LABORATORIES (US) 1992-08-25 US disclosed
EP-0402646-A1 Retroviral protease inhibiting compounds ABBOTT LABORATORIES (US) 1990-12-19 EP disclosed